226 related articles for article (PubMed ID: 16328067)
1. High energy shock waves enhance the cytotoxic effect of doxorubicin and methotrexate to human osteosarcoma cell lines.
Palmero A; Berger M; Venturi C; Ferrero I; Rustichelli D; Berta L; Frairia R; Madon E; Fagioli F
Oncol Rep; 2006 Jan; 15(1):267-73. PubMed ID: 16328067
[TBL] [Abstract][Full Text] [Related]
2. 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a promising new candidate for chemotherapeutic treatment of osteosarcoma patients.
Pasello M; Hattinger CM; Stoico G; Manara MC; Benini S; Geroni C; Mercuri M; Scotlandi K; Picci P; Serra M
Eur J Cancer; 2005 Sep; 41(14):2184-95. PubMed ID: 16140527
[TBL] [Abstract][Full Text] [Related]
3. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis in osteogenic sarcoma cells by combination of tumor necrosis factor-related apoptosis inducing ligand and chemotherapeutic agents.
Sun J; Fu ZM; Fang CQ; Li JH
Chin Med J (Engl); 2007 Mar; 120(5):400-4. PubMed ID: 17376311
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines.
Murayama T; Kawasoe Y; Yamashita Y; Ueno Y; Minami S; Yokouchi M; Komiya S
Anticancer Res; 2008; 28(4B):2147-54. PubMed ID: 18751388
[TBL] [Abstract][Full Text] [Related]
6. Alpha-tocopheryl succinate alters cell cycle distribution sensitising human osteosarcoma cells to methotrexate-induced apoptosis.
Alleva R; Benassi MS; Pazzaglia L; Tomasetti M; Gellert N; Borghi B; Neuzil J; Picci P
Cancer Lett; 2006 Feb; 232(2):226-35. PubMed ID: 16458119
[TBL] [Abstract][Full Text] [Related]
7. Anti-MDR1 siRNA restores chemosensitivity in chemoresistant breast carcinoma and osteosarcoma cell lines.
Perez J; Bardin C; Rigal C; Anthony B; Rousseau R; Dutour A
Anticancer Res; 2011 Sep; 31(9):2813-20. PubMed ID: 21868524
[TBL] [Abstract][Full Text] [Related]
8. Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma.
Pasello M; Michelacci F; Scionti I; Hattinger CM; Zuntini M; Caccuri AM; Scotlandi K; Picci P; Serra M
Cancer Res; 2008 Aug; 68(16):6661-8. PubMed ID: 18701490
[TBL] [Abstract][Full Text] [Related]
9. High energy shock waves (HESW) for sonodynamic therapy: effects on HT-29 human colon cancer cells.
Canaparo R; Serpe L; Catalano MG; Bosco O; Zara GP; Berta L; Frairia R
Anticancer Res; 2006; 26(5A):3337-42. PubMed ID: 17094450
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic effects of C-glycosides in HOS and HeLa cell lines.
Sanhueza CA; Mayato C; Machín RP; Padrón JM; Dorta RL; Vázquez JT
Bioorg Med Chem Lett; 2007 Jul; 17(13):3676-81. PubMed ID: 17482817
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative and antimigratory effects of doxorubicin in human osteosarcoma cells exposed to extracellular matrix.
Harisi R; Dudás J; Tímár F; Pogány G; Paku S; Tímár J; Kovalszky I; Szendroi M; Jeney A
Anticancer Res; 2005; 25(2A):805-13. PubMed ID: 15868912
[TBL] [Abstract][Full Text] [Related]
12. IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell lines.
Luk F; Yu Y; Walsh WR; Yang JL
Cancer Invest; 2011 Oct; 29(8):521-32. PubMed ID: 21843050
[TBL] [Abstract][Full Text] [Related]
13. Effects of shock waves on tenocyte proliferation and extracellular matrix metabolism.
Chao YH; Tsuang YH; Sun JS; Chen LT; Chiang YF; Wang CC; Chen MH
Ultrasound Med Biol; 2008 May; 34(5):841-52. PubMed ID: 18222032
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo.
Ottewell PD; Deux B; Mönkkönen H; Cross S; Coleman RE; Clezardin P; Holen I
Clin Cancer Res; 2008 Jul; 14(14):4658-66. PubMed ID: 18628481
[TBL] [Abstract][Full Text] [Related]
15. Shock wave permeabilization with ribosome inactivating proteins: a new approach to tumor therapy.
Delius M; Adams G
Cancer Res; 1999 Oct; 59(20):5227-32. PubMed ID: 10537301
[TBL] [Abstract][Full Text] [Related]
16. High energy shock waves (HESW) enhance paclitaxel cytotoxicity in MCF-7 cells.
Frairia R; Catalano MG; Fortunati N; Fazzari A; Raineri M; Berta L
Breast Cancer Res Treat; 2003 Sep; 81(1):11-9. PubMed ID: 14531493
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of osteogenic sarcoma].
Tateishi A
Gan No Rinsho; 1989 Jan; Spec No():483-90. PubMed ID: 2915497
[No Abstract] [Full Text] [Related]
18. Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300-resistant cell lines.
Yin JQ; Shen JN; Su WW; Wang J; Huang G; Jin S; Guo QC; Zou CY; Li HM; Li FB
Acta Pharmacol Sin; 2007 May; 28(5):712-20. PubMed ID: 17439728
[TBL] [Abstract][Full Text] [Related]
19. Pemetrexed, a multitargeted antifolate drug, demonstrates lower efficacy in comparison to methotrexate against osteosarcoma cell lines.
Bodmer N; Walters DK; Fuchs B
Pediatr Blood Cancer; 2008 Apr; 50(4):905-8. PubMed ID: 17534933
[TBL] [Abstract][Full Text] [Related]
20. Shock wave-induced ATP release from osteosarcoma U2OS cells promotes cellular uptake and cytotoxicity of methotrexate.
Qi B; Yu T; Wang C; Wang T; Yao J; Zhang X; Deng P; Xia Y; Junger WG; Sun D
J Exp Clin Cancer Res; 2016 Oct; 35(1):161. PubMed ID: 27716441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
